: Lilly’s COVID-19 remedy receives emergency-use approval from FDA, inventory jumps 3%

Eli Lilly & Co.’s COVID-19 antibody remedy was accepted for emergency use by the Meals and Drug Administration on Monday, and Lilly shares jumped greater than 3% in after-hours buying and selling.

Learn Full Story

Newest posts by Market Watch (see all)